🔗 Permalink

Inventor profile of:

Li Ou

City:

Potomac, Maryland

Country:

United States

Published Applications:

Last publication date:

2026-05-28

Top Assignees for applications by Li Ou

The entities that hold a legal rights for patent applications filed by inventor Ou Li:

The United States of America, as represented by the Secretary, Department of Health and Human Services 7 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Servic 6 Bethesda, MD United States
The USA, as represented by the Secretary, Department of Health and Human Services 2 Bethesda, MD United States
INSTITUTE FOR RESEARCH IN BIOMEDICINE 2 Bellinzona, Switzerland
The United States of America,as represented by the Secretary,Department of Health and Human Services 1 Bethesda, MD United States
The University of North Carolina at Chapel Hill 1 Chapel Hill, NC United States
Board of Regents, The University of Texas System 1 Austin, TX United States
The United States of America, as represented by the Secretary, Department of Health and Human Servi 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human 1 Bethesda, MD United States
The United States of America, as represented by the Secretay, Deparment of Health and human Servi 1 Bethesda, MD United States
The United State of America, as represented by the Secretary, Department of Health & Human Services 1 Bethesda, MD United States
The United States of America, As Represented by the Secretary, Department of Health & Human Services 1 Bethesda, MD United States

Recent patent applications by Ou Li

Li Ou from Potomac, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-28

US20260144860A1

Human necessities

HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE

#2 | 2026-01-22

US20260022145A1

Chemistry; metallurgy

PREFUSION PIV F IMMUNOGENS AND THEIR USE

#3 | 2025-12-25

US20250388627A1

Chemistry; metallurgy

PREFUSION RSV F PROTEINS AND THEIR USE

#4 | 2024-09-12

US20240299510A1

Human necessities

ANTIBODY-GUIDED PCSK9-MIMICKING IMMUNOGENS LACKING 9-RESIDUE SEQUENCE OVERLAP WITH HUMAN PROTEINS

#5 | 2024-07-11

US20240228549A1

Chemistry; metallurgy

PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE

#6 | 2024-06-27

US20240209032A1

Chemistry; metallurgy

Prefusion RSV F proteins and their use

#7 | 2024-03-28

US20240101609A1

Chemistry; metallurgy

PREFUSION PIV F IMMUNOGENS AND THEIR USE

#8 | 2023-11-30

US20230381293A1

Human necessities

STABILIZED NOROVIRUS VIRUS-LIKE PARTICLES AS VACCINE IMMUNOGENS

#9 | 2023-10-26

US20230338507A1

Human necessities

HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE

#10 | 2023-06-08

US20230174587A1

Chemistry; metallurgy

RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE

#11 | 2022-03-03

US20220064222A1

Chemistry; metallurgy

Prefusion RSV F proteins and their use

#12 | 2021-11-18

US20210353740A1

Human necessities

HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use

#13 | 2020-07-23

US20200230229A1

Human necessities

HIV-1 Env fusion peptide immunogens and their use

#14 | 2019-04-18

US20190112340A1

Chemistry; metallurgy

Substitutions-modified prefusion RSV F proteins and their use

InventorID:

2480431 ⎘